News Archives - Page 14 of 1183 - BioHealth Innovation

News

December 10, 2024

Frederick’s Alithea Genomics Launches Full-Length DRUG-Seq to Unlock Full Power of Transcriptomics for Drug Discovery

Multiplexed, extraction-free, full-length library preparation technology facilitates large-scale RNA sequencing, combining ever more content with high throughput FREDERICK, Md., Dec. 9,…

Andy

Love0

News

December 6, 2024

FY25 MBIA Commercialization Innovation Grant Applications Open December 10

The Maryland Business Innovation Association (MBIA), with support from TEDCO, has announced the launch of the FY25 MBIA Commercialization Innovation…

Andy

Love0

News

December 6, 2024

BDC and Maryland Department of Commerce Announce Board of Estimates Approval of Conditional Loan for 4MLK Flex Lab Space

Baltimore, MD—The Baltimore Development Corporation (BDC) and the Maryland Department of Commerce are pleased to announce the Baltimore City Board…

Andy

Love0

News

December 6, 2024

Children’s National, FDA collaborate to advance pediatric device regulatory tools

WASHINGTON (Dec. 4, 2024) — In a significant collaboration to help advance pediatric health, Children’s National Hospital and the U.S.…

Andy

Love0

News

December 4, 2024

Advancing MRI Metabolic Imaging: Join NCI’s Upcoming Technology Opportunity Webinar

The National Cancer Institute (NCI) Technology Transfer Center is hosting a webinar on an exciting new technology that could revolutionize…

Andy

Love0

News

December 3, 2024

Cartesian Reports Positive Phase 2b Results for Descartes-08 in Myasthenia Gravis and Previews Phase 3 Trial

FREDERICK, Md., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering…

Andy

Love0

News

December 2, 2024

Gaithersburg’s Shuttle Pharma Begins Phase 2 Trial of Ropidoxuridine for Glioblastoma at UVA Cancer Center

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development…

Andy

Love0

News

December 2, 2024

Revolutionizing Respiratory Care: Linshom Medical’s Journey to Innovation and Recognition on BioTalk

In this episode of BioTalk, host Rich Bendis welcomes Ric Hughen, CEO of Linshom Medical, and Talia Feldman, Software Engineer at Linshom Medical,…

Andy

Love0

News

November 27, 2024

University of Maryland Institute for Health Computing Celebrates Second Anniversary

Uncovering bias in AI models used in medical diagnosis. Identifying patients with potentially life-threatening antibiotic-resistant infections. Predicting the spread of…

Andy

Love0

News

November 27, 2024

Arlington Capital Partners Acquires TEAM Technologies

Washington, D.C. – November 25, 2024 – Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated…

Andy

Love0

News

Frederick’s Alithea Genomics Launches Full-Length DRUG-Seq to Unlock Full Power of Transcriptomics for Drug Discovery

FY25 MBIA Commercialization Innovation Grant Applications Open December 10

BDC and Maryland Department of Commerce Announce Board of Estimates Approval of Conditional Loan for 4MLK Flex Lab Space

Children’s National, FDA collaborate to advance pediatric device regulatory tools

Advancing MRI Metabolic Imaging: Join NCI’s Upcoming Technology Opportunity Webinar

Cartesian Reports Positive Phase 2b Results for Descartes-08 in Myasthenia Gravis and Previews Phase 3 Trial

Gaithersburg’s Shuttle Pharma Begins Phase 2 Trial of Ropidoxuridine for Glioblastoma at UVA Cancer Center

Revolutionizing Respiratory Care: Linshom Medical’s Journey to Innovation and Recognition on BioTalk

University of Maryland Institute for Health Computing Celebrates Second Anniversary

Arlington Capital Partners Acquires TEAM Technologies

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search